Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions
Familial Hypercholesterolemia
Interventions
OTHER

Cascade Screening

FH is a genetic condition that causes high LDL cholesterol starting at birth. When one individual with FH is diagnosed, it is important that biological family members are also screened, since there is a 50% chance that each first-degree relative will have also inherited FH. More distant relatives may also have inherited FH. This evidence-based process is known as cascade screening.

Trial Locations (1)

19104

University of Pennsylvania, Perelman School of Medicine, Philadelphia

All Listed Sponsors
collaborator

Family Heart Foundation

UNKNOWN

collaborator

University of Pennsylvania

OTHER

lead

Northwestern University

OTHER